June 3, 2013 — Medtronic Inc. announced it has received CE mark for valve-in-valve (VIV) procedures using the CoreValve and CoreValve Evolut transcatheter aortic valve implantation (TAVI) systems...
June 3, 2013 — OrbusNeich has launched the world's first dual-therapy stent to address the challenges of delayed healing of the coronary artery associated with monotherapy drug-eluting stents (DES...
May 31, 2013 — The American Society of Echocardiography (ASE) released a new expert consensus statement this week focusing on the practice of using ultrasound as a tool for improving patient...
Digisonics will exhibit its Enterprise PACS and structured reporting solutions for cardiology, OB/GYN, radiology and general ultrasound studies at this year’s Society for Imaging Informatics in...
Interventional cardiology treats cardiovascular disease, an illness currently afflicting one in every three Americans. Its affects range from high-blood pressure to a fatal stroke. ...
May 30, 2013 — Cerebral function is the essence of quality of life. Its preservation throughout medical procedures is a key component to procedural success and patient care. New scientific data...
May 30, 2013 — Kona Medical announced three and six month results from the WAVE I study, a first-in-man study evaluating the safety and efficacy of Kona Medical’s Surround Sound Renal...
Whether it is a magnetic resonance imaging (MRI), computed tomography (CT) or other type of imaging system, reliable power protection is critical for the proper operation and uptime of imaging...
Today’s healthcare is changing in many ways and so are the processes, technology and people delivering the extremely complex cardiology procedures and services. There are multiple biomedical and...
Transradial coronary artery angiography was a major focus at the Society for Cardiovascular Angiography Interventions (SCAI) 2013 Scientific Sessions May 8-11 in Orlando, Fla. The meeting kicked-...
May 29, 2013 — The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted in all of the first 60 patients in results from REPRISE II,...
May 28, 2013 — The U.S. District Court for the District of New Jersey approved an agreement under which Vascular Solutions Inc. will cease further manufacture, sales and distribution of its R...
May 28, 2013 — Abbott announced CE mark in Europe for the Xience Xpedition 48 Everolimus Eluting Coronary Stent System, the first-of-its-kind treatment for very long blockages in the vessels that...
